Buprofezin hapten, buprofezin artificial antigen and preparation and application thereof

By designing the coupling of thiazide hapten with carrier protein and preparing artificial antigens, combined with immunochromatography technology, the complex and time-consuming method for detecting thiazide residues in the existing technology is solved, and fast, accurate and low-cost can be achieved detection effect.

CN119019344AActive Publication Date: 2024-11-26SHENZHEN DRAWRAY BIOTECH CO LTD +2
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411117536.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-11-26
Estimated Expiration
2044-08-15

AI Technical Summary

Technical Problem

The existing methods for detecting thiazide pesticide residues are complex, time-consuming and costly under laboratory conditions, which are difficult to meet the needs of large numbers of samples and on-site rapid testing, and the detection accuracy is not high and it is prone to false positive or false negative results.

Method used

Design a thiazide hapten coupled to carrier protein, prepare artificial antigen, and quickly detect test strips combining thiazide polyclonal antibody and colloidal gold through immunochromatography to achieve rapid and accurate detection of thiazide in the sample .

Benefits of technology

It realizes rapid, sensitive and highly specific detection of thiazide residues, reduces detection costs, is suitable for large-scale samples and on-site monitoring, and improves the accuracy and reliability of detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019344A_ABST
    Figure CN119019344A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of food safety, in particular to a buprofezin hapten, an artificial antigen and preparation and application of the buprofezin hapten and the artificial antigen. The structural formula of the buprofezin hapten is as follows: # imgabs0 #. The design of the hapten is carried out based on a buprofezin compound as a raw material, and the synthesized hapten can simulate the structural integrity of a target analyte in a highly similar manner; and after the introduced succinic anhydride which is an active group is coupled with macromolecular protein to prepare the artificial antigen, the immune response reaction can be better caused, and a high-performance antibody is generated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of food safety, and in particular to a thiazide hapten, an artificial antigen, and preparation and application thereof. Background Art

[0002] Buprofezin, also known as buprofezin and rice thief, is a new type of selective insecticide that inhibits the growth and development of insects. It has strong contact and stomach poison effects, and is characterized by high activity, high selectivity, and long residual effect. It can effectively prevent and control planthoppers and leafhoppers on rice, leafhoppers on tea and potatoes, whiteflies on citrus and vegetables, shield scales and mealybugs on citrus, and can also prevent and control scale insects on fruit trees and tea trees. It is often used for pest control of rice and vegetables. However, improper use will lead to excessive levels of buprofezin in foods such as vegetables, fruits, and tea, which will cause damage to people's health. As people pay more and more attention to food safety, the limit requirements for drug residues in vegetables and fruits are becoming increasingly stringent. In order to ensure consumer interests and food safety, my country's national standard GB 2763-2021 "National Food Safety Standard Maximum Residue Limits of Pesticides in Foods" stipulates the maximum residue limits of buprofezin in food.

[0003] At present, the main methods for detecting thiamethoxam pesticide residues include gas chromatography (GC), high performance liquid chromatography (HPLC), gas chromatography mass spectrometry (GC / MS), liquid chromatography mass spectrometry (LC / MS) and enzyme-linked immunosorbent assay (ELISA). These methods must be operated under laboratory conditions, sample pretreatment is cumbersome and time-consuming, and expensive instruments and equipment are required. The detection cost is high, time-consuming, and the operation is complicated. There are great limitations in the actual application process, and it is difficult to meet the needs of rapid detection of a large number of samples and field samples. Among them, the enzyme-linked immunosorbent assay kit: a known antibody or antigen is combined with a certain solid phase carrier and its immune activity is maintained; during the determination, the sample to be tested and the enzyme-labeled antigen or antibody react with the antibody or antigen adsorbed on the surface of the solid phase carrier in different steps; the antigen-antibody complex and the free component are separated by washing; finally, the enzyme substrate is added to catalyze the color development, and the standard curve is obtained according to the known amount of residual substance standard curve and the inhibition rate of the sample to be tested, and then the semi-logarithmic relationship between the inhibition rate and the concentration of the residual substance is obtained, so as to infer the concentration of the substance to be tested. For each target protein of enzyme-linked immunosorbent assay, a primary antibody that can specifically bind to it needs to be prepared, and the experimental flexibility is low; the detection accuracy is not high, and the test results are affected by many factors, and false positive or false negative results may occur; the experimental operation is complicated, and the operation process needs to be strictly controlled, which is easily affected by the external environment and may cause errors, and supporting instruments are required for data analysis, and there are differences between different instruments.

[0004] Compared with the above methods, the immunochemical detection method has the advantages of rapid, specific, sensitive, accurate, batch monitoring, simple sample processing, and automated operation for drug detection. The premise of immunochemical detection of thiazin is the need to have antibodies against thiazin, and obtaining high-performance antibodies depends on the structural design of the hapten. Therefore, the molecular design and synthesis of the immune hapten is the most basic and critical step in producing high-performance antibodies and establishing small molecule pesticide residue rapid detection technology. The current preparation of thiazin hapten (patent application number: CN202211388260.1) is not carried out with thiazin compounds as raw materials, but is synthesized step by step through a series of compounds, and the integrity of the original structure cannot be guaranteed.

[0005] In view of this, this application is hereby filed. Summary of the invention

[0006] One or more embodiments of the present application provide a thiazinone hapten, an artificial antigen, and preparation and application thereof, including the following technical solutions:

[0007] One or more embodiments of the present application provide a thiazinone hapten, the structural formula of the thiazinone hapten is as follows:

[0008]

[0009] One or more embodiments of the present application provide a method for preparing the thiazinone hapten, the method comprising introducing compound I into The steps for preparing thiazinone hapten are described in detail.

[0010] One or more embodiments of the present application provide an artificial antigen, which includes a carrier protein and the thiazinone hapten coupled to the carrier protein;

[0011] Optionally, the carrier protein is bovine serum albumin and / or ovalbumin.

[0012] One or more embodiments of the present application provide a method for preparing the artificial antigen, which comprises: mixing the carrier protein and the thiazinone hapten for a coupling reaction to prepare the artificial antigen.

[0013] One or more embodiments of the present application provide a method for preparing a polyclonal antibody against thiazinone, the method comprising the steps of immunizing a mammal with an immunogen and isolating the polyclonal antibody against thiazinone from the serum of the immunized mammal;

[0014] Wherein, the immunogen is the artificial antigen;

[0015] Optionally, the mammal comprises a lagomorph.

[0016] One or more embodiments of the present application provide a thiazinone polyclonal antibody, which is prepared by the preparation method.

[0017] One or more embodiments of the present application provide a thiazinone immunoassay test strip, wherein the thiazinone immunoassay test strip comprises one or more of the thiazinone polyclonal antibody and the artificial antigen.

[0018] In some embodiments of the present application, the thiazide immunoassay test strip comprises the thiazide polyclonal antibody and the artificial antigen.

[0019] In some embodiments of the present application, the thiazide immunoassay test strip comprises a sample pad, a conjugate gold pad, a reaction membrane and a water absorbent pad sequentially assembled on a bottom plate along a chromatography direction, and a detection line and a quality control line are provided on the reaction membrane;

[0020] The conjugate gold pad is coated with a conjugate, which includes the coupled thiazinone polyclonal antibody and colloidal gold; the quality control line is coated with a quality control protein, which specifically binds to the thiazinone polyclonal antibody; and the detection line is coated with the artificial antigen.

[0021] One or more embodiments of the present application provide a method for preparing the thiazinone immunoassay test strip, which comprises the step of preparing the thiazinone immunoassay test strip using one or more of the thiazinone polyclonal antibody and the artificial antigen.

[0022] One or more embodiments of the present application provide a method for detecting thiazide, which comprises the step of using the thiazide polyclonal antibody or the thiazide immunoassay test strip to detect thiazide in a sample to be tested.

[0023] In some embodiments of the present application, the sample to be tested is a vegetable sample, a fruit sample or a grain sample.

[0024] The details of one or more embodiments of the present application are set forth in the description which follows, and other features, objects, and advantages of the present application will be apparent from the description and its claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] In order to more clearly illustrate the technical solutions in the embodiments of the present application and to more completely understand the present application and its beneficial effects, the following is a brief introduction to the drawings required for the description of the embodiments. Obviously, the drawings described below are only some embodiments of the present application, and those skilled in the art can obtain other drawings based on these drawings without creative work.

[0026] Figure 1 A synthetic route for the thiazinone hapten;

[0027] Figure 2 Schematic diagram of the cross-sectional structure of the test strip;

[0028] Figure 3 This is a diagram for determining the test results of the test strip. DETAILED DESCRIPTION

[0029] The present application will be further described in detail below in conjunction with the accompanying drawings, embodiments and examples. It should be understood that these embodiments and examples are only used to illustrate the present application and are not used to limit the scope of the present application. The purpose of providing these embodiments and examples is to make the understanding of the disclosure of the present application more thorough and comprehensive. It should also be understood that the present application can be implemented in many different forms, is not limited to the embodiments and examples described herein, and those skilled in the art can make various changes or modifications without violating the connotation of the present application, and the equivalent form obtained also falls within the protection scope of the present application. In addition, in the description below, a large number of specific details are given in order to provide a more comprehensive understanding of the present application, and it should be understood that the present application can be implemented without one or more of these details.

[0030] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which this application belongs. The terms used herein in the specification of this application are only for the purpose of describing implementation modes and embodiments and are not intended to limit this application.

[0031] the term

[0032] Unless otherwise specified or incompatible herewith, the terms and phrases used herein shall have the following meanings:

[0033] The terms "and / or", "or / and", and "and / or" used in this article include any one of two or more related listed items, and also include any and all combinations of related listed items, and the arbitrary and all combinations include any two related listed items, any more related listed items, or a combination of all related listed items. It should be noted that when at least three items are connected by at least two conjunctions selected from "and / or", "or / and", and "and / or", it should be understood that in this application, the technical solution undoubtedly includes technical solutions that are all connected by "logical and", and undoubtedly includes technical solutions that are all connected by "logical or". For example, "A and / or B" includes three parallel solutions of A, B and A+B. For example, the technical solution of "A, and / or, B, and / or, C, and / or, D" includes any one of A, B, C, and D (that is, the technical solution that is all connected by "logical OR"), and also includes any and all combinations of A, B, C, and D, that is, the combination of any two or any three of A, B, C, and D, and also includes the combination of four of A, B, C, and D (that is, the technical solution that is all connected by "logical AND").

[0034] In the present application, "plurality", "multiple", "multiple times", "multiples", etc., unless otherwise specified, refer to a number greater than 2 or equal to 2. For example, "one or more" means one or greater than or equal to two.

[0035] As used herein, "combination thereof", "any combination thereof", "any combination thereof" etc. include all suitable combinations of any two or more of the listed items.

[0036] Herein, the “suitable” mentioned in “suitable combination”, “suitable method”, “any suitable method”, etc., shall be based on the ability to implement the technical solution of this application, solve the technical problems of this application, and achieve the expected technical effects of this application.

[0037] Herein, “preferred”, “better”, “more preferred” and “suitable” are merely used to describe implementation methods or examples with better effects, and it should be understood that they do not constitute limitations on the scope of protection of this application.

[0038] In the present application, "further", "further", "particularly" and the like are used for descriptive purposes to indicate differences in content, but should not be construed as limiting the scope of protection of the present application.

[0039] In this application, "optionally", "optional", and "optional" mean optional or dispensable, that is, any one of the two parallel schemes of "yes" or "no". If multiple "options" appear in a technical solution, unless otherwise specified and there is no contradiction or mutual restriction, each "optional" is independent.

[0040] In the present application, the terms "first", "second", "third", "fourth", etc. in "the first aspect", "the second aspect", "the third aspect", "the fourth aspect", etc. are used only for descriptive purposes and cannot be understood as indicating or implying relative importance or quantity, nor can they be understood as implicitly indicating the importance or quantity of the indicated technical features. Moreover, "first", "second", "third", "fourth", etc. only serve the purpose of non-exhaustive enumeration and description, and it should be understood that they do not constitute a closed limitation on quantity.

[0041] In the present application, the technical features described in an open manner include closed technical solutions composed of the listed features, and also include open technical solutions containing the listed features.

[0042] In the present application, when it comes to numerical intervals (i.e., numerical ranges), unless otherwise specified, the optional numerical distribution is considered continuous within the above numerical interval, and includes the two numerical endpoints (i.e., the minimum and maximum values) of the numerical range, and each numerical value between the two numerical endpoints. Unless otherwise specified, when the numerical interval only refers to the integers within the numerical interval, it includes the two endpoint integers of the numerical range, and each integer between the two endpoints. In this article, it is equivalent to directly listing each integer, such as t is an integer selected from 1 to 10, indicating that t is any integer selected from the group of integers consisting of 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10. In addition, when multiple ranges are provided to describe features or characteristics, these ranges can be combined. In other words, unless otherwise specified, the ranges disclosed herein should be understood to include any and all subranges included therein.

[0043] The temperature parameters in this application, unless otherwise specified, are allowed to be either constant temperature treatment or to vary within a certain temperature range. It should be understood that the constant temperature treatment allows the temperature to fluctuate within the accuracy range controlled by the instrument. Fluctuations within the range of ±5°C, ±4°C, ±3°C, ±2°C, and ±1°C are allowed.

[0044] In the present application, % (w / w) and wt% both represent weight percentage, % (v / v) refers to volume percentage, and % (w / v) refers to mass volume percentage.

[0045] All documents mentioned in this application are cited as references in this application, just as each document is cited as reference separately. Unless they conflict with the application purpose and / or technical solution of this application, the cited documents involved in this application are cited with all contents and all purposes. When the cited documents are involved in this application, the definitions of relevant technical features, terms, nouns, phrases, etc. in the cited documents are also cited. When the cited documents are involved in this application, the examples and preferred methods of the cited relevant technical features can also be incorporated into this application as references, but are limited to the implementation of this application. It should be understood that when the cited content conflicts with the description in this application, the present application shall prevail or be modified adaptively according to the description of this application.

[0046] Immunoassay methods have attracted more and more attention in the field of pesticide residue detection because of their strong specificity, simple operation, and ability to rapidly detect a large number of samples. Therefore, it is necessary to establish an efficient immunoassay method. However, this method is determined by the performance of antigens and antibodies, and the structural design of haptens is a factor in obtaining high-performance antibodies.

[0047] In a first aspect of the embodiments of the present application, a thiazinone hapten is provided, and the structural formula of the thiazinone hapten is as follows:

[0048]

[0049] The embodiment of the present application provides a novel thiazide hapten, which is coupled with a carrier protein. The prepared complete antigen can produce highly efficient antibodies, and utilizes the specific immunological reaction of the antigen and antibody and the amplification effect of easily detectable and identifiable markers to detect ultra-trace small molecule targets in samples, which can be used for sample determination. The key to this application is the molecular design and synthesis of the hapten and the preparation of the complete antigen and antibody.

[0050] The present application designs haptens based on thiazinone compounds as raw materials, retains the chemical structure of thiazinone to the maximum extent, and the synthesized haptens can simulate the integrity of the target analyte structure with high similarity, and the introduced active group of succinic anhydride can better induce immune response after coupling with macromolecular protein to prepare artificial antigen, and can specifically identify thiazinone and produce high-performance antibodies. On the whole, the hapten improves the specificity of the hapten and adds reaction sites to the antigen preparation. The corresponding antibodies are applied to colloidal gold immunochromatography rapid test strips, which are time-consuming, simple to operate, and low in cost, and are suitable for large-scale detection of samples at grassroots units.

[0051] In a second aspect of the present invention, a method for preparing the thiazinone hapten is provided, wherein the method comprises introducing The steps for preparing thiazinone hapten are described in detail.

[0052] The present application does not specifically limit the specific steps of introducing succinic anhydride, including but not limited to Figure 1 The synthetic route shown and the specific steps recorded under item 1.1 of Example 1.

[0053] According to a third aspect of the embodiments of the present application, an artificial antigen is provided, which includes a carrier protein and the thiazinone hapten coupled to the carrier protein.

[0054] In some embodiments, the carrier protein is bovine serum albumin and / or ovalbumin. In some embodiments, the carrier protein is bovine serum albumin, and the corresponding artificial antigen can be used to immunize animals to produce corresponding antibodies. In some embodiments, the carrier protein is ovalbumin, and the corresponding artificial antigen can be used as a coating source to be coated on the detection line of the immunoassay test strip to compete with the antigen in the sample for antibodies.

[0055] The fourth aspect of the embodiments of the present application provides a method for preparing the artificial antigen, the method comprising: mixing the carrier protein and the thiazinone hapten for a coupling reaction to prepare the artificial antigen.

[0056] The present application does not particularly limit the method for preparing the artificial antigen, including but not limited to the preparation steps under Item 1.2 and the preparation steps under Item 1.3 in Example 1.

[0057] In a fifth aspect of the embodiments of the present application, there is provided a method for preparing a polyclonal antibody against thiazinone, the method comprising the steps of immunizing a mammal with an immunogen and isolating the polyclonal antibody against thiazinone from the serum of the immunized mammal;

[0058] Wherein, the immunogen is the artificial antigen;

[0059] Optionally, the mammal comprises a lagomorph.

[0060] In a sixth aspect of the embodiments of the present application, a thiazinone polyclonal antibody is provided, wherein the thiazinone polyclonal antibody is prepared by the preparation method.

[0061] In a seventh aspect of an embodiment of the present application, a thiazinone immunoassay test strip is provided, wherein the thiazinone immunoassay test strip comprises one or more of the thiazinone polyclonal antibody and the artificial antigen.

[0062] Optionally, the thiazide immunoassay test strip comprises the thiazide polyclonal antibody and the artificial antigen.

[0063] In some embodiments, the thiazide immunoassay test strip comprises a sample pad, a conjugate gold pad, a reaction membrane and a water absorbent pad sequentially assembled on a bottom plate along a chromatography direction, and a detection line and a quality control line are provided on the reaction membrane;

[0064] Among them, the conjugate gold pad is coated with conjugate 1, and the conjugate includes the coupled thiazinone polyclonal antibody and colloidal gold; the quality control line is coated with quality control protein, and the quality control protein specifically binds to the thiazinone polyclonal antibody; the detection line is coated with the artificial antigen.

[0065] The thiazinone rapid test strip of the embodiment of the present application adopts highly specific antibody-antigen reaction and competitive inhibition immunochromatographic analysis technology to fix the thiazinone polyclonal antibody-colloidal gold conjugate on the conjugate gold pad. The thiazinone in the sample specifically binds to the thiazinone polyclonal antibody-colloidal gold conjugate on the conjugate gold pad during the flow process to form a thiazinone drug-antibody-colloidal gold complex. The thiazinone drug in the sample competes with the thiazinone hapten-carrier protein conjugate on the reaction membrane detection line to bind to the thiazinone polyclonal antibody-colloidal gold conjugate, and the presence or absence of a red strip on the detection line or the depth of color is used to determine whether the sample liquid to be tested contains thiazinone residues.

[0066] During the detection process, the sample is treated and then dropped onto the sample pad of the test strip. When the concentration of thiazinone in the sample is lower than the detection limit (including zero), the thiazinone polyclonal antibody-colloidal gold conjugate will specifically bind to the thiazinone hapten-carrier protein conjugate fixed on the reaction membrane during the chromatography process, and a red strip will appear in the detection line (T) and the quality control line (C); if the concentration of thiazinone in the sample is equal to or higher than the detection limit, the thiazinone polyclonal antibody-colloidal gold conjugate will completely bind to the thiazinone, so that no red strip will appear at the T line because it will not bind to the thiazinone hapten-carrier protein conjugate due to the competitive reaction.

[0067] The test strip of the present application has the advantages of high sensitivity, strong specificity, low cost, simple operation, short detection time, suitable for use by various units, simple storage, and long shelf life. The method of using the test strip of the present invention to detect thiamethoxam residues is simple, rapid, intuitive, accurate, widely applicable, low cost, and easy to promote and use.

[0068] The embodiments of the present application overcome the existing methods for detecting thiamethoxam, which are highly dependent on detection equipment and cannot realize rapid detection of large batches of samples. The embodiments of the present application have high sensitivity and can realize rapid detection and on-site monitoring of large batches of thiamethoxam samples.

[0069] In the present application, the second quality control protein includes but is not limited to goat anti-rabbit IgG.

[0070] In an eighth aspect of an embodiment of the present application, a method for preparing the thiazin immunoassay test strip is provided, the preparation method comprising the step of preparing the thiazin immunoassay test strip using one or more of the thiazin polyclonal antibody and the artificial antigen.

[0071] In a ninth aspect of the embodiments of the present application, a method for detecting thiazide is provided, the method comprising the step of using the thiazide polyclonal antibody and the thiazide immunoassay test strip to detect thiazide in a sample to be tested.

[0072] Optionally, the sample to be tested is a vegetable sample, a fruit sample or a grain sample.

[0073] The concentration of concentrated sulfuric acid is usually 98.3%. This concentration refers to the mass fraction of sulfuric acid in the solution, that is, the proportion of pure sulfuric acid in the solution. Concentrated sulfuric acid is a highly corrosive strong mineral acid, and its chemical properties include dehydration, low volatility, acidity, and water absorption. In practical applications, the concentration of concentrated sulfuric acid is often adjusted to about 98%, because sulfuric acid solution at this concentration has strong corrosiveness and oxidizing properties, and can be used in many chemical reactions and laboratory operations.

[0074] Concentrated hydrochloric acid is a highly corrosive chemical substance. Its concentration is usually expressed as mass fraction. The concentration range of commercially available concentrated hydrochloric acid is roughly between 36% and 38%. The concentration of concentrated hydrochloric acid used in experiments is also roughly within this range. The specific value may vary slightly depending on the production batch and purpose.

[0075] The embodiments of the present application will be described in detail below in conjunction with examples. It should be understood that these examples are only used to illustrate the present application and are not intended to limit the scope of the present application. The experimental methods for which specific conditions are not specified in the following examples are preferably referred to the guidance provided in the present application, and can also be based on the experimental manual or normal conditions in this area, can also be based on the conditions recommended by the manufacturer, or refer to experimental methods known in the art.

[0076] In the following specific embodiments, the measured parameters of raw material components may have slight deviations within the range of weighing accuracy unless otherwise specified. For temperature and time parameters, acceptable deviations caused by instrument test accuracy or operation accuracy are allowed.

[0077] Example 1

[0078] 1. Preparation of Buprofezin Test Strips

[0079] The preparation method of the test strip mainly comprises the following steps:

[0080] (1) preparing a gold pad sprayed with a conjugate of thiazinone antibody-colloidal gold label;

[0081] (2) preparing a reaction membrane having a detection line coated with a thiazinone hapten-BSA conjugate and a quality control line coated with a goat anti-rabbit IgG;

[0082] (3) Assemble the gold pad, reaction membrane, sample absorption pad, water absorption pad and bottom plate prepared in step (1) and step (2) into a test strip.

[0083] The following is a detailed step-by-step description:

[0084] 1.1 Synthesis of thiazinone hapten (synthesis route see attached Figure 1 )

[0085] 3g of compound I was slowly added into 10mL of concentrated sulfuric acid cooled to 0℃ and completely dissolved, then 1g of KNO3 was slowly added, and the reaction was allowed to proceed at low temperature (temperature was 0℃) for 3 hours, and then the pH was adjusted to 5-7 with NaHCO3, and extracted with dichloromethane for 3 times, the aqueous phase was removed, the organic phase was evaporated to dryness, and recrystallized with petroleum ether and ethyl acetate to obtain 1.4g of compound II;

[0086] The total amount of compound II (1.4 g) was added with SnCl2·2H2O (6.8 g) and concentrated hydrochloric acid (20 mL), reacted at 60°C for 6 h, adjusted to pH 8-9 with NaHCO3, extracted with dichloromethane for 3 times, the aqueous phase was removed, and the organic phase was evaporated to dryness to obtain compound III (1 g);

[0087] To 1 g of the total compound III, add 70 mL of dilute sulfuric acid (concentration of 4 mol / L), cool to 0°C, slowly add 0.17 g of sodium nitrite solution (concentration of 2.5 mmol), react at 0°C for 3 h, add 150 mL of dilute sulfuric acid (concentration of 4 mol / L), react at 45°C for 3 h, cool to room temperature, adjust pH to 6-7 with NaHCO3, extract 3 times with dichloromethane, remove the aqueous phase, and evaporate the organic phase to obtain 0.6 g of compound IV;

[0088] 0.2 g of compound IV and 0.23 g of succinic anhydride were dissolved in pyridine, and 300 μL of triethylamine and 0.05 g of 4-dimethylaminopyridine (DMAP) were added. The reaction was refluxed overnight, and the solution after the reaction was separated and purified by column chromatography. The separated and purified reactant was then dissolved in methanol. The molar ratio of the separated and purified reactant to methanol was 1:5. Then, 1 mol / L aqueous sodium hydroxide solution was added and stirred at room temperature for 3 to 5 hours. After the reaction, the pH was adjusted to 6 to 7 with 1 mol / L hydrochloric acid. The resulting precipitate was the hapten product compound V.

[0089] 1.2 Preparation of immunogen

[0090] Take 5 mg of compound V, 3 mg of NHS (activating agent N-hydroxysuccinimide) and 10 mg of EDC (dehydrating agent carbodiimide) and dissolve them in 50-100 μL DMF (N,N-dimethylformamide), stir at room temperature in the dark for 2-4 hours to obtain thiazinone hapten activation solution A;

[0091] Weigh 20 mg of bovine serum albumin (BSA) and add it to 1 mL of PBS buffer (0.01 mol / L, pH = 7.4) to dissolve to obtain liquid B; slowly add liquid A dropwise into liquid B, stir at 4 ° C for 12 h, stop the reaction, dialyze and purify with 0.01 mol / L PBS for 3 days, change the liquid 3 times a day, centrifuge and package to obtain thiazide hapten-BSA conjugate, which is the immunogen.

[0092] 1.3 Preparation of coating

[0093] Similar to the preparation method of the immunogen, 5 mg of compound V was coupled with 10 mg of ovalbumin OVA in a PBS buffer solution at pH 7.4, and the thiazinone hapten-OVA conjugate was obtained after purification by dialysis to obtain the coating source.

[0094] 1.4 Preparation of Buprofezin Antibodies

[0095] The immunogen prepared in step 1.2 (immunogen concentration is 5 mg / mL) and the immune adjuvant (incomplete Freund's adjuvant is used for the first immunization, and incomplete Freund's adjuvant is used for subsequent booster immunization) are emulsified uniformly in a volume ratio of 1:1, and New Zealand white rabbits are immunized. The New Zealand white rabbits weigh 2.5-3 kg, and multiple subcutaneous injections are used in the neck and back. The second immunization is performed 4 weeks later, and booster immunization is performed once every 3 weeks thereafter, and the injection dose is 1 mg each time. Blood is collected from the ear vein one week after the third booster immunization, and the serum titer is determined by indirect competitive ELISA. When the titer no longer rises, booster immunization is performed using the ear vein. One week later, blood is collected from the heart, and the collected blood is obtained by warming for 0.5-1h at 37°C, then standing overnight at 4°C, and then the precipitated serum is sucked with a pipette, followed by centrifugation at 3000-5000rpm for 10min at 4°C, and the supernatant is taken. The antiserum was purified by ammonium sulfate precipitation to obtain polyclonal antibodies against thiazolinone and stored at -20°C for future use.

[0096] 1.5 Preparation of thiazinone antibody-colloidal gold conjugate

[0097] (1) Preparation of colloidal gold

[0098] Dilute 1% chloroauric acid to 0.01% (mass fraction) with double distilled deionized water, take 100 mL and place it in a conical flask, heat it to boiling with a constant temperature electromagnetic stirrer, add 125 mL 1% trisodium citrate under continuous high temperature and continuous stirring, continue to stir and heat at a uniform speed until the solution turns translucent red, stop, cool to room temperature, and store at room temperature. The prepared colloidal gold has a pure, translucent appearance, without precipitation and floating matter.

[0099] (2) Preparation of thiazinone antibody-colloidal gold conjugate and conjugate gold pad

[0100] The colloidal gold solution was adjusted to pH 7.0 with 0.1 mol / L potassium carbonate solution, stirred and mixed for 15 minutes, and then 5 μg of antibody was added per milliliter of colloidal gold solution (colloidal gold concentration was 0.0001 mol / L), and thiazide polyclonal antibody was added to the colloidal gold solution. After stirring for 20 minutes, 20% BSA was added to make the final concentration in the final product 1% (volume fraction), and stirred and mixed for 25 minutes. Centrifuged at 10000 rpm / min and 4°C for 20 minutes, the supernatant was discarded, and the solution was reconstituted with a reconstitution buffer with a volume of 1 / 10 of the initial colloidal gold solution, and sprayed on the conjugate pad at a spray volume of 2.0 μL / cm.

[0101] 1.6 Preparation of reaction membrane and sample pad

[0102] Take 0.2 mg / mL coating source and 0.1 mg / mL goat anti-rabbit IgG, spray them on the nitrocellulose membrane 4 with a film scribing machine at a spray volume of 1.0 μL / cm, and prepare the detection line 5 and the quality control line 6 respectively. Place the sprayed nitrocellulose membrane 4 in a 37°C vacuum drying oven and dry it for 24 hours, wherein the dilution coating solution of 0.2 mg / mL coating source and 0.1 mg / mL goat anti-rabbit IgG are both PBS buffer with a mass fraction of 1% trehalose and a pH value of 7.4.

[0103] 1.7 Preparation of sample pad

[0104] The sample absorption pad was pre-moistened with the sample treatment solution and placed in a 37°C drying oven to dry for 24 h.

[0105] 1.8 Assembly of test strips

[0106] According to the attached Figure 2 The cross-sectional structure of the test strip shown in the figure is that the sample absorption pad 2, the coupled gold pad 3, the reaction membrane 4, and the water absorption pad 7 are pasted on the bottom plate 1 in order, and the sample absorption pad covers the coupled gold pad. Finally, it is cut into small strips with a width of 4 mm, placed in a special plastic card shell, and sealed with an aluminum foil bag. It can be stored for 12 months at 4 to 30°C.

[0107] 2. Detection of Buprofezin Residues in Samples

[0108] 2.1 Sample pretreatment

[0109] Cut the sample to be tested into pieces less than 1 cm square. Weigh 1±0.1g of sample into a 15mL polystyrene centrifuge tube, add 3mL of sample extract, cover the tube, vortex or manually oscillate up and down for 1min, let stand for 2min, the supernatant is the sample solution, melon vegetables absorb 100μL of sample solution and add 900μL of sample extract solution, vortex and mix well to obtain the test solution.

[0110] The sample extract is a PB buffer solution with a concentration of 0.02M and a pH value of 7.4, wherein the PB buffer solution contains 0.5% by volume of Triton X-405 and 0.01% by mass of PC300.

[0111] 2.2 Testing with test strips

[0112] Use a pipette to draw up the sample solution to be tested and vertically drip 3 to 4 drops into the sample well. Start timing when the liquid flows, and let it react for 5 to 10 minutes before determining the result.

[0113] 2.3 Analysis of test results

[0114] If the color of the test line (T) is darker than or equal to the color of the quality control line (C), the result is negative; if the color of the test line (T) is lighter than that of the C line, or the test line (T) does not show color, the result is positive; if the quality control line (C) does not show color, it may be due to improper operation or invalid test paper card. It is recommended to retest with a new test paper card. Figure 3 .

[0115] 3. Sample testing examples

[0116] 3.1 Detection limit example

[0117] Take blank cucumber, pumpkin and wax gourd samples, add thiamethoxam to the final concentrations of 0.35 mg / kg, 0.7 mg / kg and 1.4 mg / kg respectively; take test strips for testing, and repeat the measurement 3 times for each sample.

[0118] When the test strips were used to test cucumber, pumpkin and wax gourd samples, when there was no thiamethoxam and its added concentration was 0.35 mg / kg, the test strips showed that the color of the T line was darker than the color of the C line or the same as the color of the C line, which was negative; when the added concentration of thiamethoxam was 0.7 mg / kg and 1.4 mg / kg, the test strips showed that the color of the T line was lighter than the color of the C line or had no color with the T line, which was positive, indicating that the detection limit of this test strip for thiamethoxam in melons is 0.7 mg / kg.

[0119] 3.2 Sensitivity, false positive rate, and false negative rate test

[0120] 50 blank cucumber, pumpkin, wax gourd samples and 50 positive cucumber, pumpkin, wax gourd samples with thiamethoxam added to the final concentration of 0.7 mg / kg and 1.4 mg / kg were tested with three batches of test strips. The results are shown in Table 1.

[0121] Table 1. Experimental results of performance index determination

[0122]

[0123]

[0124] The results show that the performance indicators of the test strip of the present application are sensitivity ≥ 99% and false negative rate ≤ 1%, indicating that the test strip for detecting thiamethoxam in the present application can quickly detect thiamethoxam residues in melon samples.

[0125] 3.3 Specificity test

[0126] 100 μg / L of thiamethoxam, triazophos, methyl isofosate, methomyl, clothianidin and other drugs were prepared respectively, and tested with this test strip, repeated 3 times, to determine the specificity of the test strip. The results showed that the test strips were all negative, that is, there was no cross with the above drugs, indicating that the test strip had good specificity.

[0127] The technical features of the above-mentioned implementation modes and examples can be combined in any appropriate manner. To make the description concise, not all possible combinations of the technical features in the above-mentioned implementation modes and examples are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0128] The above-described embodiments only express several implementation methods of the present application, which is convenient for understanding the technical solution of the present application in detail, but it cannot be understood as a limitation on the scope of protection of the patent application. It should be pointed out that for ordinary technicians in this field, without departing from the concept of the present application, several deformations and improvements can be made, which all belong to the protection scope of the present application. In addition, it should be understood that after reading the above-mentioned teaching content of the present application, the technicians in this field can make various changes or modifications to the present application, and the equivalent forms obtained also fall within the protection scope of the present application. It should also be understood that the technical solutions obtained by the technicians in this field through logical analysis, reasoning or limited experiments on the basis of the technical solutions provided in the present application are all within the protection scope of the claims attached to the present application. Therefore, the protection scope of the patent of the present application shall be based on the content of the attached claims, and the description and drawings can be used to explain the content of the claims.

Claims

1. A thiazide hapten, characterized in that: The structural formula of the thiazinone hapten is as follows:

2. The method for preparing the thiazinone hapten according to claim 1, characterized in that: The preparation method comprises introducing compound I into The steps for preparing thiazinone hapten are described in detail.

3. An artificial antigen, characterized in that: The artificial antigen comprises a carrier protein and the thiazinone hapten according to claim 1 coupled to the carrier protein; Optionally, the carrier protein is bovine serum albumin and / or ovalbumin.

4. The method for preparing an artificial antigen according to claim 3, characterized in that: The preparation method comprises: mixing the carrier protein and the thiazinone hapten to carry out a coupling reaction to prepare an artificial antigen.

5. A method for preparing a thiazolinone polyclonal antibody, characterized in that: The preparation method comprises the steps of immunizing a mammal with an immunogen and isolating thiazinone polyclonal antibodies from the serum of the immunized mammal; Wherein, the immunogen is the artificial antigen according to claim 3; Optionally, the mammal comprises a lagomorph.

6. A thiamethoxam polyclonal antibody, characterized in that: The thiazinone polyclonal antibody is prepared by the preparation method according to claim 5.

7. A thiamethoxam immunoassay test strip, characterized in that: The thiazinone immunoassay test strip comprises one or more of the thiazinone polyclonal antibody according to claim 6 and the artificial antigen according to claim 3; Optionally, the thiazide immunoassay test strip comprises the thiazide polyclonal antibody and the artificial antigen.

8. The oxazinone immunoassay test strip according to claim 7, characterized in that: The thiazide immunoassay test strip comprises a sample pad, a coupling gold pad, a reaction membrane and a water-absorbing pad which are sequentially assembled on a bottom plate along a chromatography direction, and a detection line and a quality control line are arranged on the reaction membrane; The conjugate gold pad is coated with a conjugate, which includes the coupled thiazinone polyclonal antibody and colloidal gold; the quality control line is coated with a quality control protein, which specifically binds to the thiazinone polyclonal antibody; and the detection line is coated with the artificial antigen.

9. The method for preparing the oxazinone immunoassay test strip according to any one of claims 7 to 8, characterized in that: The preparation method comprises the step of preparing a buprofezin immunoassay test strip using one or more of the buprofezin polyclonal antibody according to claim 6 and the artificial antigen according to claim 3.

10. A method for detecting thiamethoxam, characterized in that: The detection method comprises the step of using the thiazin polyclonal antibody described in claim 6 or the thiazin immunoassay test strip described in claim 7 or 8 to detect thiazin in the sample to be tested; optionally, the sample to be tested is a vegetable sample, a fruit sample or a grain sample.

Citation Information

Patent Citations

  • Preparation method and application of buprofezin hapten, complete antigen and antibody

    CN115745990A

  • Buprofezin monoclonal hybridoma cell strain, antibody, colloidal gold test strip, enzyme-linked immunosorbent assay kit and application

    CN116716257A